CIK 0001821586 · Large accelerated filer
MoonLake Immunotherapeutics
Sign in to watch- Ticker
- MLTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 41 41 510 8022
- Business address
- DORFSTRASSE 29, ZUG, Switzerland, 6300
- Former names
- Helix Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-14 | Bodenstedt Matthias Chief Financial Officer | Sale 10b5-1 | −2,426 | $19.56 | $47K | 1,186,084 |
| 2026-04-13 | Santos da Silva Jorge Chief Executive Officer | Sale | −51,873 | $18.23 | $946K | 2,924,893 |
| 2026-04-10 | Santos da Silva Jorge Chief Executive Officer | Sale | −98,127 | $18.41 | $1.8M | 2,976,766 |
| 2026-04-10 | Bodenstedt Matthias Chief Financial Officer | Sale 10b5-1 | −1,925 | $19.51 | $38K | 1,188,510 |
| 2026-04-09 | Bodenstedt Matthias Chief Financial Officer | Sale 10b5-1 | −85,870 | $18.94 | $1.6M | 1,190,435 |
| 2026-03-31 | BVF PARTNERS L P/IL Director | Sale | −1,932,354 | $16.79 | $32.4M | 8,302,735 |
| 2026-03-31 | BVF PARTNERS L P/IL Director | Sale | −1,569,116 | $16.79 | $26.3M | 6,599,722 |
| 2026-03-31 | BVF PARTNERS L P/IL Director | Sale | −248,530 | $16.79 | $4.2M | 1,039,238 |
| 2026-01-07 | Bodenstedt Matthias Chief Financial Officer | Grant or award | +354,296 | 1,276,305 | ||
| 2026-01-07 | Santos da Silva Jorge Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +520,342 | 520,342 | ||
| 2026-01-07 | Reich Kristian Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +520,342 | 520,342 | ||
| 2025-12-19 | Bodenstedt Matthias Chief Financial Officer | Conversion | +294,473 | 922,009 | ||
| 2025-12-19 | Bodenstedt Matthias Chief Financial Officer | Returned to the company | −294,473 | 0 | ||
| 2025-12-19 | Bodenstedt Matthias Chief Financial Officer | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −8,754 | 0 | ||
| 2025-12-19 | Reich Kristian Chief Scientific Officer | Conversion | +35,389 | 35,389 | ||
| 2025-12-19 | Reich Kristian Chief Scientific Officer | Returned to the company | −35,389 | 0 | ||
| 2025-12-19 | Reich Kristian Chief Scientific Officer | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −1,052 | 0 | ||
| 2025-12-19 | Santos da Silva Jorge Chief Executive Officer | Conversion | +196,316 | 3,074,893 | ||
| 2025-12-19 | Santos da Silva Jorge Chief Executive Officer | Returned to the company | −196,316 | 0 | ||
| 2025-12-19 | Santos da Silva Jorge Chief Executive Officer | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −5,836 | 0 |
Page 2 of 10 · 184 trades